Transrepression Assay Services

INDIGO Biosciences provides transrepression assay services to help drug discovery teams evaluate how compounds modulate transcription factor signaling through pathway cross-talk and selective modulation. These studies enable direct measurement of transrepression mechanisms, supporting a more complete understanding of compound activity in endocrine or inflammatory signaling systems.

Request a Study Consultation

GR/NF-κB Transrepression in
INDIGO's Cell-Based Reporter Assays

Transrepression is a mechanism in which one transcription factor suppresses the activity of another without directly binding DNA at the regulated promoter. This can occur through protein-protein interactions, competition for co-regulators, or recruitment of co-repressors, resulting in reduced transcriptional activity.

A well-characterized example is glucocorticoid receptor (GR)-mediated suppression of NF-κB signaling. In this context, activated GR suppresses NF-κB-driven transcription, providing a functional readout of pathway cross-talk relevant to anti-inflammatory compound characterization and to the evaluation of Selective Glucocorticoid Receptor Modulators (SGRMs).

INDIGO Biosciences currently offers GR/NF-κB transrepression studies in cell-based reporter assay systems, enabling customers to evaluate this specific interaction in a controlled in vitro format and to support programs focused on selective glucocorticoid receptor modulator activity.

For programs involving other transcription factor pathways, INDIGO’s scientists can discuss whether a customized reporter assay approach may be suitable for evaluating additional forms of transcription factor cross-talk or pathway-selective suppression.

INDIGO’s Transrepression Assay Platform

INDIGO’s transrepression assays are based on our luciferase reporter system that measure changes in transcription factor–driven signaling following pathway induction.

INDIGO's defined experimental conditions may include:

A transcription factor pathway is activated using a controlled stimulus
Compounds are applied to evaluate modulation of signaling
Changes in reporter signal are measured as a functional readout of transrepression

This approach enables sensitive, quantitative detection of transcription factor cross-talk in a high-throughput in vitro format.

Our transrepression assays provide a valuable extension to standard reporter assay approaches, offering deeper insight into transcription factor cross-talk and pathway-selective compound activity.

Why Choose INDIGO’s Transrepression Assay Services?

Physiologically Relevant Cell-Based Reporter Assay Systems

INDIGO’s transrepression assays utilize cell-based reporter systems designed to measure transcription factor activity under controlled induction conditions. These systems support evaluation of signaling interactions in a biologically relevant cellular environment.

Quantitative and Reproducible Data

Our platform supports:

Potency, efficacy, and dose-response analysis
Direct comparison of compound series
Mechanistic interpretation of transcription factor-mediated suppression

These outputs provide clear, quantitative insight into transcription factor–mediated suppression.

Actionable Data for Mechanistic Insight

Transrepression assays enable:

Identification of pathway-selective compound activity
Differentiation of compounds with similar activation profiles
Integration with nuclear receptor and pathway reporter assay data

This supports informed decision-making during hit-to-lead and lead optimization stages.

Scientific Support from INDIGO’s Team

INDIGO’s scientists work directly with your team to:

Align assay conditions with your signaling pathways of interest
Support study design and execution
Provide guidance on data interpretation and follow-up studies

Talk To One of Our Scientists

INDIGO’s transrepression assay services can support programs focused on:

Selective glucocorticoid receptor modulator characterization
Anti-inflammatory compound profiling
Functional selectivity assessment across related reporter assay formats
Hit-to-lead and lead optimization studies
Mechanistic follow-up after nuclear receptor or pathway reporter screening
Custom evaluation of transcription factor cross-talk and pathway-selective suppression